Sheaff Brock Investment Advisors’s Clovis Oncology, Inc. CLVS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-14,351
| Closed | -$83K | – | 562 |
|
2021
Q2 | $83K | Buy |
14,351
+2,500
| +21% | +$14.5K | 0.01% | 506 |
|
2021
Q1 | $84K | Buy |
+11,851
| New | +$84K | 0.01% | 476 |
|
2020
Q4 | – | Sell |
-14,591
| Closed | -$85K | – | 508 |
|
2020
Q3 | $85K | Buy |
14,591
+3,000
| +26% | +$17.5K | 0.01% | 431 |
|
2020
Q2 | $78K | Sell |
11,591
-2,010
| -15% | -$13.5K | 0.01% | 422 |
|
2020
Q1 | $87K | Buy |
+13,601
| New | +$87K | 0.01% | 371 |
|
2018
Q3 | – | Sell |
-4,446
| Closed | -$202K | – | 542 |
|
2018
Q2 | $202K | Sell |
4,446
-2,780
| -38% | -$126K | 0.02% | 445 |
|
2018
Q1 | $382K | Buy |
7,226
+850
| +13% | +$44.9K | 0.04% | 296 |
|
2017
Q4 | $434K | Buy |
6,376
+1,476
| +30% | +$100K | 0.06% | 283 |
|
2017
Q3 | $404K | Buy |
4,900
+675
| +16% | +$55.7K | 0.05% | 299 |
|
2017
Q2 | $396K | Buy |
4,225
+700
| +20% | +$65.6K | 0.05% | 325 |
|
2017
Q1 | $224K | Buy |
+3,525
| New | +$224K | 0.03% | 477 |
|